- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07905794
Development of a Body Hygiene Assessment Scale for Bedbound Individuals
Development of a Body Hygiene Status Assessment Scale for Bedbound Individuals
This study aims to develop a valid and reliable assessment scale for evaluating body hygiene status in bedbound individuals. Maintaining body hygiene is an essential component of nursing care, particularly for patients who depend on others for daily activities.
The study is designed as a methodological study involving sequential qualitative and quantitative phases. Initially, semi-structured interviews will be conducted with intensive care nurses experienced in providing hygiene care to bedbound patients. The findings, together with relevant literature, will inform the development of an initial item pool.
Following item development and preliminary evaluation, the draft scale will be tested in at least 100 bedbound patients. Further psychometric evaluation will be conducted using a sample size determined according to the final number of scale items.
Body hygiene status will be assessed through observation during routine nursing care. No experimental treatment, invasive procedure, or additional medical intervention will be performed. The study aims to provide a standardized instrument to support the assessment of body hygiene status in bedbound individuals.
Visão geral do estudo
Status
Condições
Descrição detalhada
This methodological study aims to develop the Body Hygiene Status Assessment Scale for Bedbound Individuals and evaluate its validity and reliability. The study will be conducted at Bolu Izzet Baysal State Hospital, Türkiye, using sequential qualitative and quantitative phases.
**Phase 1: Qualitative Exploration and Item Development**
Individual semi-structured interviews will be conducted with approximately 10-15 intensive care nurses experienced in providing hygiene care to bedbound patients. Interviews will explore relevant anatomical regions, observable indicators of hygiene status, and nurses' professional experiences. Each interview is expected to last approximately 20-30 minutes, and interviews will continue until data saturation is reached. Findings from the qualitative phase and relevant literature will inform the development of the initial item pool.
**Phase 2: Preliminary Evaluation**
The draft scale will undergo preliminary evaluation to assess the clarity and feasibility of its items before pilot testing.
**Phase 3: Pilot Testing**
The pilot study will include at least 100 bedbound individuals meeting the eligibility criteria. Exploratory factor analysis and item analyses will be performed to examine the factor structure, refine the items, and determine the final number of scale items.
**Phase 4: Main Psychometric Evaluation**
Confirmatory factor analysis will be conducted in an independent sample that does not include participants from the pilot study. The main study sample size will be determined based on at least 10 participants per final scale item. The validity and reliability of the developed scale will be evaluated.
**Informed Consent and Participant Safety**
Written informed consent will be obtained directly from patients with decision-making capacity. For patients unable to provide informed consent, written consent will be obtained from their legally authorized representatives.
Body hygiene status will be assessed through direct observation during routine nursing care and hygiene procedures, only when the relevant anatomical regions are already visible. No additional exposure of body regions, invasive procedures, experimental treatments, or interventions beyond routine care will be performed. Patient privacy, comfort, and confidentiality will be maintained throughout the study.
The scale development process will be informed by contemporary measurement development principles and relevant COSMIN recommendations.
Tipo de estudo
Inscrição (Estimado)
Contactos e Locais
Contato de estudo
- Nome: Saadet Can Çiçek, PhD
- Número de telefone: +90 506 284 69 36
- E-mail: saadet.cancicek@ibu.edu.tr
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Método de amostragem
População do estudo
The study population will include intensive care nurses experienced in providing hygiene care to bedridden patients and adult bedridden inpatients. Nurses will participate in the qualitative phase to inform the development of scale items. Bedridden patients will participate in the subsequent pilot testing and psychometric validation of the scale.
Descrição
Inclusion Criteria:
Qualitative Phase (Nurses):
- Aged 18 years or older.
- Intensive care nurses experienced in providing hygiene care to bedridden patients.
- Voluntary participation in individual interviews.
Scale Development and Validation Phase (Patients):
- Aged 18 years or older.
- Bedridden patients receiving inpatient care.
- Eligible for hygiene assessment during routine nursing care.
Exclusion Criteria:
- Not meeting the inclusion criteria for the relevant study phase.
- Declining participation or withdrawing consent, where applicable.
- Any additional exclusion criteria specified in the approved study protocol.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Modelos de observação: OTHER
- Perspectivas de Tempo: PROSPECTIVE
Coortes e Intervenções
Grupo / Coorte |
|---|
|
Qualitative Interview Group
Approximately 10-15 intensive care nurses experienced in providing hygiene care to bedbound patients will participate in individual semi-structured interviews. The findings will inform the development of the initial scale item pool. |
|
Pilot Psychometric Evaluation Group
At least 100 bedbound patients meeting the eligibility criteria will be assessed using the draft Body Hygiene Status Assessment Scale. Exploratory factor analysis and item analyses will be performed to examine the preliminary factor structure and refine the scale items. |
|
Main Psychometric Validation Group
An independent sample of bedbound patients, excluding participants from the pilot study, will be evaluated using the refined Body Hygiene Status Assessment Scale. The sample size will be determined based on at least 10 participants per final scale item. Confirmatory factor analysis and reliability analyses will be conducted to evaluate the psychometric properties of the scale. |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Construct Validity of the Body Hygiene Status Assessment Scale
Prazo: At the single study assessment (baseline), conducted once during routine nursing care.
|
The construct validity of the Body Hygiene Status Assessment Scale will be evaluated using exploratory factor analysis (EFA) in a pilot sample of at least 100 bedridden patients and confirmatory factor analysis (CFA) in an independent validation sample. The scale currently consists of 10 items, each scored from 0 to 2, yielding a preliminary total score range of 0-20. Higher scores indicate better body hygiene status, whereas lower scores indicate poorer body hygiene status. Factor loadings, model fit indices, and the resulting factor structure will be examined. |
At the single study assessment (baseline), conducted once during routine nursing care.
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Internal Consistency Reliability of the Body Hygiene Status Assessment Scale
Prazo: One assessment per participant during routine nursing care and hygiene procedures.
|
Internal consistency reliability of the Body Hygiene Status Assessment Scale will be evaluated using Cronbach's alpha coefficient and item-total correlations. Reliability estimates will be calculated using data obtained from bedridden individuals assessed with the developed scale. Higher Cronbach's alpha values indicate greater internal consistency. |
One assessment per participant during routine nursing care and hygiene procedures.
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Saadet Can Çiçek, Assoc. Prof., PhD, Abant Izzet Baysal University
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Estimado)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Outros números de identificação do estudo
- AIBU- SBF- NDS- 2026
- 2026/427 (Outro identificador: Bolu Abant Izzet Baysal University Non-Interventional Clinical Research Ethics Committee)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
Individual participant data will not be publicly shared due to participant confidentiality and data protection considerations.
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .